Treatment

AMPICILLIN AND BETA-LACTAMASE INHIBITOR , COLISTIN , Rifabutin clinical trials

1 indexed studies · 0 currently recruiting

AuthorisedTherapeutic confirmatory (Phase III)
A Phase 3 prospective, randomized, multicenter, active-controlled study to evaluate the efficacy and safety of BV100 plus low-dose polymyxin B compared with colistin plus high-dose ampicillin/sulbactam in the treatment of adult patients with hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
This study is testing a new combination of medicines (BV100 with polymyxin B) for serious lung infections in hospital patients. It's looking to see if this new treatment works better and is safer than a standard treatment for infections that are hard to treat.
For: Hospital-acquired bacterial pneumonia including ventilator-associated bacterial pneumonia caused by carbapenem-resistant Acinetobacter baumannii-calcoaceticus complex
Greece